Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| AGILENT TECHNOLOGIES, INC.A · Entity 3062 | Director | February 05, 2018 | February 06, 2018 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
AGILENT TECHNOLOGIES, INC.
Report date February 05, 2018 · Filed February 06, 2018
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | IndirectHerbold Revoc Trust | 75,937.19 |
Reported balance
After 2018-02-05 transaction · row 1
Account identity is unresolved; indirect or unspecified ownership is not merged.
1 source rowRow 1 · 2018-02-05 · Exercise / conversion · Acquired 15,482 · Balance 75,937.19 |
| Non-Employee Director Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $13.89 · Expires 2018-11-17 | IndirectHerbold Revoc Trust | 0 |
Reported balance
After 2018-02-05 transaction · row 3
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 3 · 2018-02-05 · Exercise / conversion · Disposed 15,482 · Balance 0 F1: Right to buy Agilent Technologies, Inc. common stock granted under the Agilent Technologies, Inc. 1999 Non-Employee Director Stock Plan. F2: This option is fully vested and exercisable. |
| Common StockSEC Table I · non-derivative | IndirectBy IRA | 2,500.002 |
Reported balance
Holding disclosure · report date 2018-02-05 · row 2
Holding and transaction disclosures are not merged.
1 source rowRow 2 · Balance 2,500.002 |
Filing footnotes · ownership attribution and instrument terms
F1: Right to buy Agilent Technologies, Inc. common stock granted under the Agilent Technologies, Inc. 1999 Non-Employee Director Stock Plan.
F2: This option is fully vested and exercisable.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| February 05, 2018 Filed Feb 6, 2018 21:30 UTC | AGILENT TECHNOLOGIES, INC. A · Entity 3062 | Exercise / conversionNon-Employee Director Stock Option (right to buy) · Derivative | 15,482 | $0.00 Strike: $13.89 | $0.00 |
DisclosureSEC source: 0001127602-18-004323 · form4.xml · derivative · entry 3 HERBOLD ROBERT J · CIK 0001142632 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · Herbold Revoc Trust Disclosed balance after: 0 Underlying: Common Stock · 15,482 shares Expires 2018-11-17 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: Right to buy Agilent Technologies, Inc. common stock granted under the Agilent Technologies, Inc. 1999 Non-Employee Director Stock Plan. F2 · derivative.exercise_date: This option is fully vested and exercisable. Read SEC document |
| February 05, 2018 Filed Feb 6, 2018 21:30 UTC | AGILENT TECHNOLOGIES, INC. A · Entity 3062 | Exercise / conversionCommon Stock | 15,482 | $13.89 | $215,044.98 |
DisclosureSEC source: 0001127602-18-004323 · form4.xml · nonDerivative · entry 1 HERBOLD ROBERT J · CIK 0001142632 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · Herbold Revoc Trust Disclosed balance after: 75,937.19 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 15, 2017 Filed May 16, 2017 20:18 UTC | AGILENT TECHNOLOGIES, INC. A · Entity 3062 | Exercise / conversionNon-Employee Director Stock Option (right to buy) · Derivative | 8,625 | $0.00 Strike: $26.16 | $0.00 |
DisclosureSEC source: 0001127602-17-018349 · form4.xml · derivative · entry 3 HERBOLD ROBERT J · CIK 0001142632 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · Herbold Revoc Trust Disclosed balance after: 0 Underlying: Common Stock · 8,625 shares Expires 2017-11-18 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: Right to buy Agilent Technologies, Inc. common stock granted under the Agilent Technologies, Inc. 1999 Non-Employee Director Stock Plan. F2 · derivative.exercise_date: This option is fully vested and exercisable. Read SEC document |
| May 15, 2017 Filed May 16, 2017 20:18 UTC | AGILENT TECHNOLOGIES, INC. A · Entity 3062 | Exercise / conversionCommon Stock | 8,625 | $26.16 | $225,630.00 |
DisclosureSEC source: 0001127602-17-018349 · form4.xml · nonDerivative · entry 1 HERBOLD ROBERT J · CIK 0001142632 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · Herbold Revoc Trust Disclosed balance after: 60,455.19 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 16, 2017 Filed Mar 17, 2017 22:43 UTC | AGILENT TECHNOLOGIES, INC. A · Entity 3062 | GrantCommon Stock | 3,866 | $53.05 | $205,091.30 |
DisclosureSEC source: 0001127602-17-012241 · form4.xml · nonDerivative · entry 1 HERBOLD ROBERT J · CIK 0001142632 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · Herbold Revoc Trust Disclosed balance after: 51,830.19 F1 · shares: Shares acquired from award of Agilent Technologies, Inc. common stock for Non-Employee Directors that are fully vested upon grant. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.